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c Instituto Universitario IVI/INCLIVA, Valencia, 46015, SpainImplantation resulting in a full-term pregnancy is, by large, more
than a passive process in which the developed conceptus is passively
glued to the uterus through adhesive molecules. It is the result of a per-
fectly orchestrated dialog between a viable embryo and a receptive en-
dometrium, through a mixture of paracrine and juxtacrine processes in
which many key proteins and growth factors play fundamental roles
(Pellicer et al., 2002.) Since their discovery, microRNAs have become
prominent regulatory candidates, providingmissing links for a few bio-
logical pathways in this process, although their exact role in human nor-
mal embryo formation and endometrial preparation for pregnancy
remains unclear (Galliano and Pellicer, 2014). Very recently it was
shown, that human endometrium delivers miRNA messages “bottled”
in protective structures such us exosomes (Ng et al., 2013) to exert a bi-
ological function in the recipient embryo (Balaguer et al., 2015). In this
issue, Cuman et al (Cuman et al., 2015) show that miRNA also travel in
the opposite way: secreted by the embryo to alter endometrial epitheli-
al adhesion. More speciﬁcally, authors show that miR-661 can be found
to be differentially over-represented in culturemedia of embryoswhich
failed to implant. Subsequently they show that mir661 is taken up by
primary human endometrial epithelial cells (HEEC) inducing the inhibi-
tion of nectin 1 (a protein mediating cell adhesion) in endometrial cells
and this results in reduced attachment of trophoblast cell line spheroids
to HEEC. Provided that in-silico analysis showed other potential pro-
teins to be regulated by mir661 it would not be surprising to uncover
in the near future complimentary mechanisms through which this
miRNA regulates embryo-maternal adhesion. Anyhow, observations in
this work highlight the importance of miRNA molecules secreted by
the embryo in initiating the event of implantation.
Selection of the best embryo for transfer is imprecise and the current
methods involve morphologic criteria (Cruz et al., 2011), on the belief
that those with a better shape are more likely to be chromosomically
normal and implant. However, many morphologically normal blasto-
cysts are aneuploid orwill not implant (Fragouli et al., 2011) whilst em-
bryos with an abnormal chromosomal content are able to do so. WithDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.09.003.
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2352-3964/© 2015 The Authors. Published by Elsevier B.V. This is an open access article underthe development of transcriptomics and massive sequence analysis it
might be hypothetically possible to detectmost of the genetic anomalies
in an embryo trough pre-implantation genetic screening (PGS). Howev-
er such approach is invasive, expensive, and requires embryo biopsy
(Winand et al., 2014). Therefore in a world where the number of IVF
cycles increase every year, there is a growing clinical interest in under-
standing embryo-maternal interactions to identify biomarkers of
embryo quality. The purpose is obvious: to increase the pregnancy
rates per transfer and reduce the presence of anomalies in them.
These biomarkers are expected to allow noninvasive analysis, be stable
over time, speciﬁc to embryos, and easily measured. Due to the fact that
miRNAs accomplish these requirements, one might envision that the
expression levels of miR661 identiﬁed by Dimiatriadis and colleagues
in non-implanted blastocysts could be employed in the future in order
to screen and select for good quality embryos suitable for subsequent
uterine transfer.
Unfortunately, we have to lower our expectation in this regard just
now, as Cuman et al study was not intended to test the predictive
value of biomarkers identiﬁed during the exploratory process. Despite
the fact that the authors conﬁrmed the overrepresentation of mir661
in a separate cohort of individual non-implanting blastocysts, the num-
ber of specimens analyzedwas small. Moreover the experimentwas not
designed to uncover the characteristics of non-implanted embryos. In
these regard, factors such as ploidy or genetic abnormalities were not
determined; indicators of low metabolic energy (Diez-Juan et al.,
2015) or embryo damage induced during ICSI (Rosenbluth et al.,
2014) were not estimated, and overall the contribution of several
other factors known to affect embryo outcome and its miRNA proﬁle
(Galliano and Pellicer, 2014)were not assessed. So the question remain-
ing is what population of non-implanted embryos overexpresses
mir661? In other words, does mir661 universally indicate embryos
fated to fail in implantation or just a very narrow and speciﬁc portion
of them? As this question remains unanswered, the repercussions in
terms of clinical usefulness of mir661 cannot currently be estimated.
This does not mean that we should neglect the potential of miR661
as a biomarker of embryo quality. It just means that further studies
should be performed to identify which speciﬁc aberrant and abnormal
embryo populations can be recognized by mir661 overexpression.
Subsequently larger double-blinded studies with an appropriate N
should be performed to test the accuracy of this marker as a predictorthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1313A. Cano, R. Gomez / EBioMedicine 2 (2015) 1312–1313of implantation outcome. As the title of this comment reﬂects, ﬁndings
provided by Cuman et al. in the context of embryo-maternal are of out-
standing scientiﬁc interest. The repercussions these observations have
in the clinical context however might suppose a major breakthrough
and therefore well worth the effort in pursuing.
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